ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

Pfizer's anti-GDF-15 antibody ponsegromab was ... After 12 weeks of treatment, patients on a 100mg dose of ponsegromab saw a 2.2% weight gain, rising to 3.48% with a 200mg dose and 4.6% with ...